The researchers evaluated changes in gastrointestinal symptoms and intestinal microbiota
Wegovy pill, from Novo Nordisk, was the first oral GLP-1 drug to be approved by the FDA, in December 2025
Caloric floor and protein minimums Regardless of how aggressively your GLP-1 medication suppresses appetite, you must maintain adequate nutrition
Older adults should be especially proactive the lean mass risks on GLP-1 drugs are amplified in people over 60
If you develop breathing difficulty, facial/lip swelling, or collapse after an injection, call 999 or attend A&E immediately
The treated fat cells themselves are destroyed and do not regenerate, so the inch-loss result is permanent provided your overall weight stays stable